Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Clinical trial NCT01165203 · COMPLETED
Trial details
- NCT number
- NCT01165203
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-30
- Primary completion
- 2012-07-06
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.